Full-Time

Program Manager

Posted on 8/8/2024

Abata Therapeutics

Abata Therapeutics

11-50 employees

Develops therapies for autoimmune diseases

Biotechnology

Senior, Expert

Belmont, MA, USA

This is an on-site position based in the Watertown, MA office and the employee will be required to work in the office on a regular basis.

Category
Lab & Research
Life Sciences
Required Skills
Management
Requirements
  • Bachelor’s degree or higher in Biology, Chemistry, Microbiology, Life Sciences, or an equivalent scientific discipline
  • 5+ years’ experience in Program Management or related function, across various stages of drug development, with proven track record of success managing multiple projects/priorities
  • Prior experience managing and working with cross-functional teams in a matrix environment
  • Prior experience in a consulting firm (BCG, etc.) is a plus
  • Travel: 0-10%
Responsibilities
  • Manage, optimize, track, and coordinate multiple workstreams across research, clinical, and technical operations to ensure key objectives and milestones are met
  • Build relationships and work cross-functionally with key stakeholders (Executive management, Program Team Leads, functional leads, external vendors and partners) to ensure alignment and drive execution of functional and program objectives
  • Identify critical path activities, resource constraints, risks, and conflicts that could impact timelines
  • Develop and optimize program management tools and processes to ensure consistency across functions and programs
  • Maintain a current overview of program status, and clearly and pro-actively communicate progress
  • Thought partner with Program Team Leads (PTLs) enabling strategic messaging and framing of key program outputs both internally and externally
  • Prepare presentation materials and participate in team discussions.

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Abata stands out in the biotech market by targeting a specific group of patients and forming strategic partnerships, like the one with ElevateBio, to enhance their research and manufacturing capabilities. The company's goal is to transform treatment options for autoimmune diseases through advanced therapies.

Company Stage

Seed

Total Funding

$184.8M

Headquarters

Cambridge, Massachusetts

Founded

2021

Growth & Insights
Headcount

6 month growth

2%

1 year growth

2%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
  • FDA's accelerated approval pathways may expedite Abata's clinical trials.
  • Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

What critics are saying

  • Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
  • Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
  • Rising clinical trial costs pose financial risks to Abata's pipeline progression.

What makes Abata Therapeutics unique

  • Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
  • Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
  • Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE